PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31966806-3	2017	The present study was performed to investigate whether cisplatin regulates the expression of IL-17E and it receptor IL-17RB, and the role of IL17E in cervical cancer cells in vitro.	Cisplatin	55-64	interleukin 25	Homo sapiens	93-99	
33536745-0	2021	CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma.	Cisplatin	66-75	interleukin 25	Homo sapiens	35-40	
33536745-10	2021	Conclusion: These data highlight the circNRIP1/miR-515-5p/IL-25 as a novel regulator of 5-Fu and cisplatin resistance in NPC, suggesting that this pathway may be amenable to therapeutic targeting as an approach to treating this cancer type.	Cisplatin	97-106	interleukin 25	Homo sapiens	58-63	
31044552-0	2019	IL-25 promotes cisplatin resistance of lung cancer cells by activating NF-kappaB signaling pathway to increase of major vault protein.	Cisplatin	15-24	interleukin 25	Homo sapiens	0-5	
31044552-4	2019	In this study, we found that both IL-25 and MVP were elevated expressed in cisplatin-resistant lung adenocarcinoma cell line (A549/CDDP).	Cisplatin	75-84	interleukin 25	Homo sapiens	34-39	
31044552-4	2019	In this study, we found that both IL-25 and MVP were elevated expressed in cisplatin-resistant lung adenocarcinoma cell line (A549/CDDP).	Cisplatin	131-135	interleukin 25	Homo sapiens	34-39	
31044552-5	2019	Silencing of IL-25 resulted in down-regulation of MVP expression and reduced cisplatin tolerance of A549/CDDP cells.	Cisplatin	77-86	interleukin 25	Homo sapiens	13-18	
31044552-6	2019	Overexpression of IL-25 resulted in increase of MVP expression and the cisplatin tolerance in A549 cells.	Cisplatin	71-80	interleukin 25	Homo sapiens	18-23	
31966806-0	2017	Cisplatin inhibits the growth, migration and invasion of cervical cancer cells by down-regulating IL-17E/IL-17RB.	Cisplatin	0-9	interleukin 25	Homo sapiens	98-104	
31966806-8	2017	Cisplatin significantly down-regulated the expression of IL-17E and IL-17RB, and further reversed the regulatory effects of rhIL-17E on viability, apoptosis, migration and invasion of HeLa and SiHa cells.	Cisplatin	0-9	interleukin 25	Homo sapiens	57-63	
31966806-9	2017	The results suggest that cisplatin inhibits the viability, migration, invasion, and promotes the apoptosis of cervical cancer cells possibly by down-regulating IL-17E/17RB signaling.	Cisplatin	25-34	interleukin 25	Homo sapiens	160-166	
31966806-10	2017	Cisplatin may be the first choice for cervical cancer patients with abnormally high IL-17E expression.	Cisplatin	0-9	interleukin 25	Homo sapiens	84-90